Veeva Announces Fiscal 2020 Third Quarter Results
Total Revenues of $280.9M, up 25% Year-over-year; Subscription Services Revenues of $226.8M, up 27% Year-over-year PLEASANTON, Calif.–(BUSINESS WIRE)–#LifeSciences–Veeva Systems Inc.…
Pharmaceuticals, Biotechnology and Life Sciences
Total Revenues of $280.9M, up 25% Year-over-year; Subscription Services Revenues of $226.8M, up 27% Year-over-year PLEASANTON, Calif.–(BUSINESS WIRE)–#LifeSciences–Veeva Systems Inc.…
LEXINGTON, Mass.–(BUSINESS WIRE)–Dicerna™ Pharmaceuticals, Inc. (Nasdaq: DRNA) (the “Company” or “Dicerna”), a leading developer of investigational ribonucleic acid interference (RNAi)…
DUBLIN–(BUSINESS WIRE)–The “Next Generation Sequencing Market by Products and Services, by Application, and by End-User: Global Industry Perspective, Comprehensive Analysis,…
DUBLIN–(BUSINESS WIRE)–The “Pharmacovigilance Market by Clinical Trial Phase, by Service Provider, by Method, and by End-User: Global Industry Perspective, Comprehensive…
LOS ANGELES–(BUSINESS WIRE)–OTITOPIC – A clinical-stage dry powder inhalation of aspirin pharmaceutical company pioneering the development of antithrombotic treatments for…
– LineaRx Functional iCTC Capture Assay Will be Used by TYME to Monitor iCTC Counts for Trial Participants – STONY…
DUBLIN–(BUSINESS WIRE)–The “RNAi Therapeutics Market (2nd Edition), 2019-2030” report has been added to ResearchAndMarkets.com’s offering. This report features an extensive…
BOSTON–(BUSINESS WIRE)–#CNS–Cerevance, a clinical stage biopharmaceutical company advancing new medicines for brain diseases, today announced that Brad Margus, chief executive…
DUBLIN–(BUSINESS WIRE)–The “Latin America Erythropoietin Stimulating Agents Market Demand Analysis & Opportunity Evaluation, 2019-2027” report has been added to ResearchAndMarkets.com’s…
BEDFORD, Mass.–(BUSINESS WIRE)–Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company pioneering a new way to treat the underlying cause of…